Cardistep I Tablet is formulated with Carvedilol 12.5mg and Ivabradine 5mg, a synergistic cardiology combination that helps in managing chronic heart failure, hypertension, and stable angina. This combination works by reducing heart rate, improving cardiac output, and lowering blood pressure, thereby reducing cardiac workload.
Carvedilol is a non-selective beta-blocker with alpha-blocking activity that helps control blood pressure and improves heart function, while Ivabradine selectively reduces heart rate without affecting myocardial contractility. Together, they provide balanced and effective cardiovascular support.
This tablet is widely prescribed by cardiologists for patients who require optimized heart rate control along with blood pressure management. Its clinical relevance makes it a strong product choice for hospital pharmacies, cardiology clinics, and institutional supply chains.
Adding Cardistep I Tablet to your cardiology therapy segment enhances portfolio strength with a high-value cardiac combination. It offers excellent scope in hospital supply, retail pharmacy distribution, export markets, and third-party manufacturing due to its consistent demand in long-term cardiovascular treatment.